Ferrofos 510 en es it fr

Ferrofos 510 Brand names, Ferrofos 510 Analogs

Ferrofos 510 Brand Names Mixture

  • No information avaliable

Ferrofos 510 Chemical_Formula


Ferrofos 510 RX_link


Ferrofos 510 fda sheet

Ferrofos 510 msds (material safety sheet)

Ferrofos 510 Synthesis Reference

No information avaliable

Ferrofos 510 Molecular Weight

391.46 g/mol

Ferrofos 510 Melting Point

No information avaliable

Ferrofos 510 H2O Solubility

10 mg/L

Ferrofos 510 State


Ferrofos 510 LogP


Ferrofos 510 Dosage Forms

Tablets (100 mg)

Ferrofos 510 Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Ferrofos 510 Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Ferrofos 510 Absorption

Well absorbed from gastrointestinal tract.

Ferrofos 510 side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Ferrofos 510 Patient Information

Ferrofos 510 Organisms Affected

Humans and other mammals